{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:39:22Z","timestamp":1791031162076,"version":"4.1.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Arizona Alzheimer's Consortium"},{"name":"State of Arizona"},{"name":"Arizona Alzheimer's Disease Core Center","award":["P30 AG19610"],"award-info":[{"award-number":["P30 AG19610"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neurobiolaging.2012.10.011","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T07:19:50Z","timestamp":1353050390000},"page":"1007-1017","source":"Crossref","is-referenced-by-count":66,"title":["APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Andrew B.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Valla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib1","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1016\/S0021-9258(18)68779-4","article-title":"Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains","volume":"263","author":"Aggerbeck","year":"1988","journal-title":"J.\u00a0Biol.Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2011-110356","article-title":"Hippocampal volume differences between healthy young apolipoprotein E \u03b52 and \u03b54 carriers","volume":"26","author":"Alexopoulos","year":"2011","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tins.2010.12.001","article-title":"Astrocyte-neuron metabolic relationships: for better and for worse","volume":"34","author":"Allaman","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib4","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.5098-09.2010","article-title":"Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability","volume":"30","author":"Allaman","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib5","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","article-title":"Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice","volume":"30","author":"Andrews-Zwilling","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.STR.0000064320.73388.C6","article-title":"Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction","volume":"34","author":"Aoki","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2002-4307","article-title":"Non-familial Alzheimer's disease is mainly due to genetic factors","volume":"4","author":"Ashford","year":"2002","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0197-4580(00)00143-3","article-title":"Neuroinflammation and Alzheimer's disease: critical roles for cytokine\/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E","volume":"21","author":"Bales","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tins.2005.01.002","article-title":"Why glucose transport in the brain matters for PET","volume":"28","author":"Barros","year":"2005","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajmg.b.30993","article-title":"APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure","volume":"153","author":"Bekris","year":"2010","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib11","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib12","doi-asserted-by":"crossref","first-page":"27063","DOI":"10.1074\/jbc.270.45.27063","article-title":"Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth","volume":"270","author":"Bellosta","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","article-title":"Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses","volume":"9","author":"Bertram","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.embor.7401126","article-title":"Multiple pathways for sorting mitochondrial precursor proteins","volume":"9","author":"Bolender","year":"2008","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","article-title":"Apolipoprotein E expression by neurons surviving excitotoxic stress","volume":"6","author":"Boschert","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1212\/01.wnl.0000228244.10416.20","article-title":"Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline","volume":"67","author":"Boyle","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib18","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI112130","article-title":"Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system","volume":"76","author":"Boyles","year":"1985","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib19","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib20","doi-asserted-by":"crossref","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","article-title":"Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors","volume":"286","author":"Brodbeck","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1440.011","article-title":"The brain's default network: anatomy, function, and relevance to disease","volume":"1124","author":"Buckner","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib23","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib24","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1073\/pnas.0508254102","article-title":"Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity","volume":"102","author":"Chang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib25","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer's disease","volume":"286","author":"Chen","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib26","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","article-title":"Small-molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons","volume":"287","author":"Chen","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/brain\/awm288","article-title":"Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease","volume":"131","author":"Ch\u00e9telat","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib28","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/brain\/awp253","article-title":"Posterior cingulate hypometabolism in early Alzheimer's disease: what is the contribution of local atrophy versus disconnection?","volume":"132","author":"Ch\u00e9telat","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib29","doi-asserted-by":"crossref","first-page":"9071","DOI":"10.1021\/bi800469r","article-title":"Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties","volume":"47","author":"Chroni","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib30","doi-asserted-by":"crossref","first-page":"2328.e1","DOI":"10.1016\/j.neurobiolaging.2011.06.016","article-title":"TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease","volume":"32","author":"Chu","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-beta in\u00a0vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in\u00a0vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib33","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal cerebral metabolism may modulate the cognitive effects of A\u03b2 in mild cognitive impairment: an example of brain reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/mp.2010.57","article-title":"Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype","volume":"16","author":"Conejero-Goldberg","year":"2011","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneurol.2011.155","article-title":"Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease","volume":"68","author":"Cruchaga","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jalz.2009.07.003","article-title":"Temporal lobe functional activity and connectivity in young adult APOE4 carriers","volume":"6","author":"Dennis","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrm2275","article-title":"Functions and dysfunctions of mitochondrial dynamics","volume":"8","author":"Detmer","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib40","doi-asserted-by":"crossref","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","article-title":"Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins","volume":"271","author":"Dong","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib41","doi-asserted-by":"crossref","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","article-title":"Human apolipoprotein E. role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms","volume":"269","author":"Dong","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib42","first-page":"1625","article-title":"Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET","volume":"46","author":"Drzezga","year":"2005","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib43","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study","volume":"30","author":"Drzezga","year":"2003","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib44","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in\u00a0vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1083\/jcb.143.3.777","article-title":"Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease","volume":"143","author":"Ebneth","year":"1998","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1073\/pnas.82.1.203","article-title":"Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets","volume":"82","author":"Elshourbagy","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib47","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib48","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1097\/01.wnr.0000234745.27571.d1","article-title":"Functional magnetic resonance imaging and magnetoencephalography differences associated with APOE e4 in young healthy adults","volume":"17","author":"Filbey","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib49","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1073\/pnas.0811879106","article-title":"Distinct patterns of brain activity in young carriers of the APOE-\u03b54 allele","volume":"106","author":"Filippini","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(85)92074-4","article-title":"Pathological and positron emission tomographic correlations in Alzheimer's disease","volume":"1","author":"Friedland","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/archneurol.2010.229","article-title":"A\u00a0randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease","volume":"68","author":"Geldmacher","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ana.410390110","article-title":"Clinical and pathological correlates of apolipoprotein E e4 in Alzheimer's disease","volume":"39","author":"Gomez-Isla","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib54","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","article-title":"Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice","volume":"100","author":"Harris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib55","doi-asserted-by":"crossref","first-page":"44795","DOI":"10.1074\/jbc.M408127200","article-title":"Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc","volume":"279","author":"Harris","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib56","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1074\/jbc.M309475200","article-title":"Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease","volume":"279","author":"Harris","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib57","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/exnr.2001.7715","article-title":"Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology","volume":"170","author":"Hartman","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib59","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jmb.2006.06.080","article-title":"Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils","volume":"361","author":"Hatters","year":"2006","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib60","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3233\/JAD-2012-120580","article-title":"Biochemical studies of poly-T variants in the Alzheimer's disease associated TOMM40 gene","volume":"31","author":"Hedskog","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib61","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/mp.2010.90","article-title":"The APOE \u03b54 allele modulates brain white matter integrity in healthy adults","volume":"16","author":"Heise","year":"2011","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib62","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1743-7075-6-31","article-title":"Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"6","author":"Henderson","year":"2009","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib63","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrn2009","article-title":"Reelin, lipoprotein receptors and synaptic plasticity","volume":"7","author":"Herz","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib64","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer' s disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.physiol.010908.163119","article-title":"Transcriptional control of mitochondrial biogenesis and function","volume":"71","author":"Hock","year":"2009","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib66","doi-asserted-by":"crossref","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib67","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1073\/pnas.92.21.9480","article-title":"Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line","volume":"92","author":"Holtzman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib68","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/jhg.2010.92","article-title":"Genomewide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease","volume":"55","author":"Hong","year":"2010","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","article-title":"Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease","volume":"16","author":"Huang","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib70","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib71","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.50.6.1585","article-title":"Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease","volume":"50","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/jcbfm.2011.120","article-title":"Proteomic analysis of mitochondria in APOE transgenic mice and in response to an ischemic challenge","volume":"32","author":"James","year":"2011","journal-title":"J.\u00a0Cereb. Blood. Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","article-title":"Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients","volume":"122","author":"Ji","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib74","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.11.012","article-title":"The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE\u03b53\/\u03b53 genotype","volume":"7","author":"Johnson","year":"2011","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib75","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/neuro.14.004.2009","article-title":"Deciphering neuron-glia compartmentalization in cortical energy metabolism","volume":"1","author":"Jolivet","year":"2009","journal-title":"Front. Neuroenergetics"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib76","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib77","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuroscience.2010.10.027","article-title":"Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2","volume":"171","author":"Klein","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1326-4-21","article-title":"ApoE isoform-dependent changes in hippocampal synaptic function","volume":"4","author":"Korwek","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib79","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","article-title":"GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice","volume":"5","author":"Li","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib80","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2004.11.003","article-title":"The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses","volume":"119","author":"Li","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib81","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.neuroimage.2010.09.066","article-title":"Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOE\u03b54 carriers","volume":"54","author":"Liang","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib82","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1073\/pnas.0709259105","article-title":"Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons","volume":"105","author":"Liang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib83","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib84","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tcb.2009.11.002","article-title":"Control of mitochondrial transport and localization in neurons","volume":"20","author":"MacAskill","year":"2010","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib85","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib86","first-page":"114","article-title":"Chylomicron remnant metabolism. role of hepatic lipoprotein receptors in mediating uptake","volume":"9","author":"Mahley","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib87","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"Mahley","year":"2000","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib88","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib89","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib90","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(94)92871-1","article-title":"Posterior cingulate cortex in Alzheimer's disease","volume":"344","author":"Minoshima","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib91","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib92","doi-asserted-by":"crossref","first-page":"50380","DOI":"10.1074\/jbc.M204898200","article-title":"Apolipoprotein E4 forms a molten globule. a potential basis for its association with disease","volume":"277","author":"Morrow","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-4-35","article-title":"Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells","volume":"4","author":"Nakamura","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib94","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","article-title":"Differential effects of apolipoproteins E3 and E4 on neuronal growth in\u00a0vitro","volume":"264","author":"Nathan","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib95","doi-asserted-by":"crossref","first-page":"19791","DOI":"10.1074\/jbc.270.34.19791","article-title":"The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization","volume":"270","author":"Nathan","year":"1995","journal-title":"J.\u00a0Biol.Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib96","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(01)03367-4","article-title":"Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein","volume":"928","author":"Nathan","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib97","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/glia.20376","article-title":"Cellular pathways of energy metabolism in the brain: is glucose used by neurons or astrocytes?","volume":"55","author":"Nehlig","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib98","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib99","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.20528","article-title":"Activity-dependent regulation of energy metabolism by astrocytes: an update","volume":"55","author":"Pellerin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"Pitas","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib101","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system. characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain","volume":"262","author":"Pitas","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib102","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s11064-011-0459-5","article-title":"TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly","volume":"36","author":"Pomara","year":"2011","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib103","doi-asserted-by":"crossref","first-page":"34948","DOI":"10.1074\/jbc.M401055200","article-title":"Apolipoprotein E receptors mediate neurite outgrowth through activation of p44\/42 mitogen-activated protein kinase in primary neurons","volume":"279","author":"Qiu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib104","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neurobiolaging.2003.12.023","article-title":"ApoE genotype accounts for the vast majority of AD risk and AD pathology","volume":"25","author":"Raber","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","article-title":"A\u00a0default mode of brain function","volume":"98","author":"Raichle","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib106","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib107","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib108","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib109","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/01.WNL.0000265401.62434.36","article-title":"Intranasal insulin improves cognition and modulates beta-amyloid in early AD","volume":"70","author":"Reger","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1196\/annals.1379.011","article-title":"Linking brain imaging and genomics in the study of Alzheimer's disease and aging","volume":"1097","author":"Reiman","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib111","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein E \u03b54 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib112","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","article-title":"Preclinical evidence of Alzheimer's disease in persons homozygous for the \u03b54 allele for apolipoprotein E","volume":"334","author":"Reiman","year":"1996","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib113","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib114","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E \u03b54 gene dose and brain-imaging measurements of regional hypometabolism","volume":"102","author":"Reiman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE \u03b54 carriers","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib116","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00702-010-0539-8","article-title":"Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults","volume":"118","author":"Richter-Schmidinger","year":"2011","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib117","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib118","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","article-title":"A\u00a0TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease","volume":"10","author":"Roses","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib119","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neurobiolaging.2007.06.010","article-title":"On the multivariate nature of brain metabolic impairment in Alzheimer's disease","volume":"30","author":"Salmon","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib157","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"Salloway","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib120","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of peroxisome proliferator-activated receptor-gamma agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib121","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/jnnp.2004.053645","article-title":"APOE related alterations in cerebral activation even at college age","volume":"76","author":"Scarmeas","year":"2005","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib122","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.290.12.1581","article-title":"APOE genotype and cerebral blood flow in healthy young individuals","volume":"290","author":"Scarmeas","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib123","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1474-4422(07)70106-0","article-title":"Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study","volume":"6","author":"Shaw","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib124","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0197-0186(01)00123-1","article-title":"Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?","volume":"40","author":"Smith","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib125","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib126","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib127","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3233\/JAD-2011-110899","article-title":"Metabolic reserve as a determinant of cognitive aging","volume":"30","author":"Stranahan","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib128","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib129","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib130","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib131","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/bi060023b","article-title":"Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4","volume":"45","author":"Tanaka","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib132","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64788-8","article-title":"Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord","volume":"157","author":"Tesseur","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib133","doi-asserted-by":"crossref","first-page":"618.e1","DOI":"10.1016\/j.neurobiolaging.2010.11.011","article-title":"The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease","volume":"33","author":"Trachtenberg","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib134","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neuroimage.2011.07.059","article-title":"The effects of APOE on the functional architecture of the resting brain","volume":"59","author":"Trachtenberg","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neurobiolaging.2010.03.009","article-title":"The effects of APOE-\u03b54 on the BOLD response","volume":"33","author":"Trachtenberg","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib136","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1073\/pnas.1010459107","article-title":"Regional aerobic glycolysis in the human brain","volume":"107","author":"Vaishnavi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib137","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1523\/JNEUROSCI.21-13-04923.2001","article-title":"Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration","volume":"21","author":"Valla","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib138","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mito.2006.10.004","article-title":"Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment","volume":"6","author":"Valla","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib139","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1179\/his.2007.30.4.235","article-title":"Quantitative cytochrome oxidase histochemistry: applications in human Alzheimer's disease and animal models","volume":"30","author":"Valla","year":"2007","journal-title":"J.\u00a0Histotechnol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-2010-100129","article-title":"Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE \u03b54 allele, the major late-onset Alzheimer's susceptibility gene","volume":"22","author":"Valla","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib141","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib142","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.1392-08.2008","article-title":"Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease","volume":"28","author":"Villain","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib143","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-\u03b2 (A\u03b2 ) deposition","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib144","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib145","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib146","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/S0021-9258(18)68778-2","article-title":"Human apolipoprotein E3 in aqueous solution. I. evidence for two structural domains","volume":"263","author":"Wetterau","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib147","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1126\/science.2063194","article-title":"Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E","volume":"252","author":"Wilson","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib148","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0166-2236(89)90165-3","article-title":"Cytochrome oxidase: an endogenous metabolic marker for neuronal activity","volume":"12","author":"Wong-Riley","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib149","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","article-title":"Specific regional transcription of apolipoprotein E in human brain neurons","volume":"154","author":"Xu","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib150","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib151","doi-asserted-by":"crossref","first-page":"25511","DOI":"10.1074\/jbc.M311256200","article-title":"Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer","volume":"279","author":"Xu","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib152","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.3253-07.2008","article-title":"Intron-3 retention\/splicing controls neuronal expression of apolipoprotein E in the CNS","volume":"28","author":"Xu","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib153","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1242\/dev.065540","article-title":"ApoE is required for maintenance of the dentate gyrus neural progenitor pool","volume":"4362","author":"Yang","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib154","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mam.2011.10.005","article-title":"Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions","volume":"32","author":"Yao","year":"2011","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib155","doi-asserted-by":"crossref","first-page":"27273","DOI":"10.1074\/jbc.M109.014464","article-title":"Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function","volume":"284","author":"Zhong","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2012.10.011_bib156","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1074\/jbc.R800009200","article-title":"Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure","volume":"284","author":"Zhong","year":"2009","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012005222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012005222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T08:10:25Z","timestamp":1643616625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012005222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":157,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0197458012005222"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.10.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}